register

News & Trends - MedTech & Diagnostics

Private hospitals take on public patient load during COVID

Health Industry Hub | June 3, 2022 |

MedTech News: Australia’s private hospitals stepped up during the COVID-19 pandemic, taking on almost a third more public hospital patients than 2019-20 to ease the burden on the public system, according to newly released data.

The Australian Institute of Health and Welfare (AIHW) ‘MyHospitals’ update releases data on hospital admissions in 2020 – 2021, the first of the COVID-19 pandemic data.

Australian Private Hospitals Association (APHA) CEO Michael Roff said the data shows the significant contribution of private hospitals to the pandemic response.

“We said at the time the private hospital viability guarantee was announced that private hospitals were ‘stepping up to the plate and doing whatever is required to help the country get through this pandemic. And the data shows that’s exactly what we did.

“The number of public patients treated by private hospitals increased from 236,515 to 312,527. This amounts to private hospitals increasing public patient separations by 32% in 2020-21. In addition, private hospitals increased the number of patients they treated in intensive care units from 36,387 separations to 52,518 separations. Private hospitals provided one in three of all ICU separations, an increase of 44%, and 18% of all separations where patients required continuous ventilatory support, up from 16.5%.”

The compelling intersection of medical devices and medical technology led to decision, says J&J Medtech MD

Mr Roff said the data does not separate COVID-19 ICU days from those occurring from other surgery, but says the significant increase shows the public system would not have coped without private hospital assistance.

“Despite private hospitals getting back to performing procedures as quickly as possible following restrictions on surgery, with surgical interventions up almost 15% – from 1,473,605 admissions in 2019-20 increasing to 1,691,215 in 2020-21 – much of this progress has already been wiped out.

“Data released by the Australian Prudential Regulation Authority last week showed more than 390,000 anticipated private hospital admissions in the past two years did not occur. Over 100,000 of these ‘missing episodes’ were added in the first three months of 2022 alone, further increasing elective surgery wait times.

“All the gains made in reducing the elective surgery backlog in 2021 have been wiped out by surgery restrictions put in place during the Omicron wave. Now we must start again.”

Mr Roff said the elective surgery backlog would continue to be a concern in both public and private hospitals for the foreseeable future with the issue exacerbated by critical health workforce shortages.

“Addressing health workforce shortages will be the first and most important issue we raise when we meet with incoming Health Minister, Mark Butler,” Mr Roff said.


News & Trends - Pharmaceuticals

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Health Industry Hub | October 11, 2024 |

Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]

More


News & Trends - Pharmaceuticals

New CVD model marks a critical step in the right direction

New CVD model marks a critical step in the right direction

Health Industry Hub | October 11, 2024 |

Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]

More


News & Trends - Pharmaceuticals

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Health Industry Hub | October 11, 2024 |

Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]

More


Leadership & Management

J&J MedTech appoints new ANZ leader

J&J MedTech appoints new ANZ leader

Health Industry Hub | October 10, 2024 |

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]

More


This content is copyright protected. Please subscribe to gain access.